Long term follow up and retrospective study on 533 gastric cancer cases

BMC Surgery

Volumn 14, Issue 1, 2014, Pages

  Zeng, Wei Juan ^a   Hu, Wen Qin ^b   Wang, Lin Wei ^a   Yan, Shu Guang ^b   Li, Jian Ding ^c   Zhao, Hao Liang ^d   Peng, Chun Wei ^a   Yang, Gui Fang ^a   Li, Yan ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b CHANGZHI MEDICAL COLLEGE   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

^d SHANXI UNIVERSITY   (China)

Author keywords

Clinical pathological factors; Gastric cancer; GC specific overall survival; Multivariate analysis; Prognosis

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; EVALUATION STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PALLIATIVE THERAPY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH TUMOR; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PALLIATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84901724970     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-14-29     Document Type: Article

References (38)

1. Estimates of worldwide burden of cancer in, GLOBOCAN 2008. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Int J Cancer 2008 2010 127 2893 2917
2. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
3. Incidence and mortality of gastric cancer in China. Yang L, World J Gastroenterol 2006 12 17 20 16440411
4. Gastric cancer. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ, Lancet 2009 374 477 490 10.1016/S0140-6736(09)60617-6 19625077
5. Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese single-institution study of 1,503 patients. Wang W, Sun XW, Li CF, Lv L, Li YF, Chen YB, Xu DZ, Kesari R, Huang CY, Li W, Zhan YQ, Zhou ZW, Ann Surg Oncol 2011 18 1060 1067 10.1245/s10434-010-1424-2 21107742
6. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases. Chen C, Chen LQ, Chen LD, Yang GL, Li Y, Hepatogastroenterology 2008 55 991 997 18705314
7. Multivariate survival and outcome analysis of 154 patients with gastric cancer at a single Chinese institution. Wu HL, Tian Q, Peng CW, Liu SP, Li Y, Asian Pac J Cancer Prev 2011 12 3341 3345 22471477
8. Surgical treatment and prognosis of gastric cancer in 2,613 patients. Zhang XF, Huang CM, Lu HS, Wu XY, Wang C, Guang GX, Zhang JZ, Zheng CH, World J Gastroenterol 2004 10 3405 3408 15526356
9. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X, Mao XH, Zou QM, Yu PW, Zuo QF, Li N, Tang B, Liu KY, Xiao B, PLoS One 2012 7 41629 10.1371/journal.pone.0041629 22860003
10. Treatment strategy of limited surgery in the treatment guidelines for gastric cancer in Japan. Yokota T, Ishiyama S, Saito T, Teshima S, Shimotsuma M, Yamauchi H, Lancet Oncol 2003 4 423 428 10.1016/S1470-2045(03)01140-9 12850193
11. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer. Diaz DLA, Yarnoz C, Aguilar R, Artieda C, Ortiz H, Gastric Cancer 2008 11 96 102 10.1007/s10120-008-0460-0 18595016
12. Full robotic gastrectomy with extended (D2) lymphadenectomy for gastric cancer: surgical technique and preliminary results. D'Annibale A, Pende V, Pernazza G, Monsellato I, Mazzocchi P, Lucandri G, Morpurgo E, Contardo T, Sovernigo G, J Surg Res 2011 166 113 e120 10.1016/j.jss.2010.11.881 21227455
13. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ, Lancet Oncol 2010 11 439 449 10.1016/S1470-2045(10) 70070-X 20409751
14. 7th edition of the AJCC cancer staging manual: stomach. Washington K, Ann Surg Oncol 2010 17 3077 3079 10.1245/s10434-010-1362-z 20882416
15. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TJ, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, et al. J Natl Compr Canc Netw 2013 11 531 546 23667204
16. Surgical treatment for peritoneal carcinomatosis from gastric cancer. Yonemura Y, Endou Y, Sasaki T, Hirano M, Mizumoto A, Matsuda T, Takao N, Ichinose M, Miura M, Li Y, Eur J Surg Oncol 2010 36 1131 1138 10.1016/j.ejso.2010.09.006 20933363
17. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, N Engl J Med 2007 357 1810 1820 10.1056/NEJMoa072252 17978289
18. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA, N Engl J Med 2001 345 725 730 10.1056/NEJMoa010187 11547741
19. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC TP, N Engl J Med 2006 355 11 20 10.1056/NEJMoa055531 16822992
20. Early and late recurrence after gastrectomy for gastric carcinoma: Univariate and multivariate analyses. Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S, Cancer 2000 89 255 261 10.1002/1097-0142(20000715)89: 2<255::AID-CNCR8>3.0.CO;2-N 10918153
21. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, Ito K, Akiyama S, Nakao A, Ann Surg Oncol 2003 10 898 902 10.1245/ASO.2003.12.009 14527908
22. Recurrence following curative resection for gastric carcinoma. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS, Br J Surg 2000 87 236 242 10.1046/j.1365-2168. 2000.01360.x 10671934
23. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement. Yang XQ, Yan L, Chen C, Hou JX, Li Y, Hepatogastroenterology 2009 56 1388 1394 19950797
24. Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity. Yang D, Hendifar A, Lenz C, Togawa K, Lenz F, Lurje G, Pohl A, Winder T, Ning Y, Groshen S, Lenz HJ, J Gastrointest Oncol 2011 2 77 84 22811834
25. Morbidity and mortality rates following gastric cancer surgery and contiguous organ removal, a population based study. Nanthakumaran S, Fernandes E, Thompson AM, Rapson T, Gilbert FJ, Park KG, Eur J Surg Oncol 2005 31 1141 1144 10.1016/j.ejso.2005.03.013 16111855
26. Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination. Li C, Yan M, Chen J, Xiang M, Zhu ZG, Yin HR, Lin YZ, J Surg Oncol 2010 102 361 365 10.1002/jso.21628 20872942
27. A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RN, Ann Surg Oncol 2009 16 51 60 10.1245/s10434-008-0192-8 18953609
28. Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer. Cheong JH, Shen JY, Song CS, Hyung WJ, Shen JG, Choi SH, Noh SH, Ann Surg Oncol 2007 14 61 68 17058123
29. Incidence and survival of stomach cancer in a high-risk population of Chile. Heise K, Bertran E, Andia ME, Ferreccio C, World J Gastroenterol 2009 15 1854 1862 10.3748/wjg.15.1854 19370783
30. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D, Freyer G, Francois Y, Vignal J, Gilly FN, Arch Surg 2004 139 20 26 10.1001/archsurg.139.1.20 14718269
31. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N, Br J Surg 2005 92 370 375 10.1002/bjs.4695 15739249
32. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B, Yonemura Y, Li Y, Ann Surg Oncol 2011 18 1575 1581 10.1245/s10434-011-1631-5 21431408
33. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, Morris DL, Ann Surg Oncol 2007 14 2702 2713 10.1245/s10434-007-9487-4 17653801
34. Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Sierzega M, Kolodziejczyk P, Kulig J, Br J Surg 2010 97 1035 1042 10.1002/bjs.7038 20632269
35. Negative impact of leakage on survival of patients undergoing curative resection for advanced gastric cancer. Yoo HM, Lee HH, Shim JH, Jeon HM, Park CH, Song KY, J Surg Oncol 2011 104 734 740 10.1002/jso.22045 21792945
36. Prognostic significance of complications after curative surgery for gastric cancer. Kubota T, Hiki N, Sano T, Nomura S, Nunobe S, Kumagai K, Aikou S, Watanabe R, Kosuga T, Yamaguchi T, Ann Surg Oncol 2014 21 891 898 10.1245/s10434-013-3384-9 24254205
37. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M, Ann Surg Oncol 2013 20 1575 1583 10.1245/s10434-012-2720-9 23076557
38. Impact of postoperative complications on long-term survival after radical resection for gastric cancer. Li QG, Li P, Tang D, Chen J, Wang DR, World J Gastroenterol 2013 19 4060 4065 10.3748/wjg.v19.i25.4060 23840153